Alimuddin Zumla

Q: What Schools Are Affiliated With Alimuddin Zumla

Alimuddin Zumla is affiliated with the following schools: University College London, University of Zambia, University of Texas Health Science Center at Houston

Alimuddin Zumla's AcademicInfluence.com Rankings

Alimuddin Zumla

Biology

#2278

World Rank

#3639

Historical Rank

Immunology

#109

World Rank

#116

Historical Rank

biology Degrees

Alimuddin Zumla

Philosophy

#2633

World Rank

#4439

Historical Rank

Logic

#685

World Rank

#1193

Historical Rank

philosophy Degrees

Download Badge

Biology
Philosophy

Alimuddin Zumla's Degrees

Masters Medicine University of Zambia

Why Is Alimuddin Zumla Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Sir Alimuddin Zumla, , FRCP, FRCPath, FRSB is a British-Zambian professor of infectious diseases and international health at University College London Medical School. He specialises in infectious and tropical diseases, clinical immunology, and internal medicine, with a special interest in HIV/AIDS, respiratory infections , and diseases of poverty. He is known for his leadership of infectious/tropical diseases research and capacity development activities. He was awarded a Knighthood in the 2017 Queens Birthday Honours list for services to public health and protection from infectious disease. In 2012, he was awarded Zambia's highest civilian honour, the Order of the Grand Commander of Distinguished services - First Division. In 2023, for the sixth consecutive year, Zumla was recognised by Clarivate Analytics, Web of Science as one of the world's top 1% most cited researchers. In 2021 Sir Zumla was elected as Fellow of The World Academy of Sciences.

(See a Problem?)

Alimuddin Zumla's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China (2020) (3009)
Real-time RT-PCR normalisation; strategies and considerations (2005) (1781)
Mandell, Douglas, and Bennett's principles and practice of infectious diseases (2010) (1398)
Coronaviruses — drug discovery and therapeutic options (2016) (1378)
Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study (2013) (1322)
Hospital outbreak of Middle East respiratory syndrome coronavirus. (2013) (1161)
Validation of housekeeping genes for normalizing RNA expression in real-time PCR. (2004) (987)
Advances in the development of new tuberculosis drugs and treatment regimens (2013) (774)
The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization. (2005) (639)
Middle East respiratory syndrome (2015) (590)
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. (2010) (549)
Family cluster of Middle East respiratory syndrome coronavirus infections. (2013) (534)
Immunological biomarkers of tuberculosis (2011) (474)
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice (2010) (450)
The WHO 2014 global tuberculosis report--further to go. (2015) (418)
Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. (2013) (418)
Single-cell landscape of immunological responses in patients with COVID-19 (2020) (399)
Honey - A Remedy Rediscovered (1989) (378)
Reducing mortality from 2019-nCoV: host-directed therapies should be an option (2020) (377)
Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial (2004) (371)
Transmission of MERS-coronavirus in household contacts. (2014) (368)
Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study (2002) (354)
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis (2012) (353)
Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission (2018) (344)
Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts (2021) (342)
Rapid Spread of Zika Virus in The Americas--Implications for Public Health Preparedness for Mass Gatherings at the 2016 Brazil Olympic Games. (2016) (339)
Scaling up interventions to achieve global tuberculosis control: progress and new developments (2012) (331)
Moving to research partnerships in developing countries (2000) (325)
Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study (2013) (324)
Epidemiology and clinical management of Legionnaires' disease. (2014) (314)
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects. (2014) (308)
Severe Acute Respiratory Syndrome (2003) (305)
Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma (2020) (304)
Immunological and inflammatory profiles in mild and severe cases of COVID-19 (2020) (276)
Hajj: infectious disease surveillance and control (2014) (268)
Spread, Circulation, and Evolution of the Middle East Respiratory Syndrome Coronavirus (2014) (265)
Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study (2010) (264)
Drug-resistant tuberculosis: time for visionary political leadership. (2013) (263)
Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD (2010) (263)
The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era. (2018) (263)
Drug-resistant tuberculosis: time for visionary political leadership. (2013) (263)
Lung remodeling in pulmonary tuberculosis. (2005) (249)
MANSON'S TROPICAL DISEASES (1988) (242)
Biomarkers for tuberculosis disease activity, cure, and relapse. (2009) (237)
Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. (2013) (236)
Host-directed therapies for infectious diseases: current status, recent progress, and future prospects (2016) (227)
Tuberculosis--advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers. (2016) (224)
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study (2017) (223)
European Union Standards for Tuberculosis Care (2012) (219)
Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study (2010) (218)
Differential susceptibility of PCR reactions to inhibitors: an important and unrecognised phenomenon (2008) (217)
Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. (2018) (217)
Tuberculosis biomarkers discovery: developments, needs, and challenges. (2013) (217)
Human Monkeypox (2019) (214)
Recognition of Stage-Specific Mycobacterial Antigens Differentiates between Acute and Latent Infections with Mycobacterium tuberculosis (2006) (214)
Imaging in tuberculosis. (2015) (210)
Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses (2020) (210)
Middle East respiratory syndrome coronavirus infections in health care workers. (2013) (203)
Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions (2001) (201)
Tuberculosis: advances and challenges in development of new diagnostics and biomarkers. (2018) (200)
Impact of HIV infection on tuberculosis (2000) (200)
WHO's 2013 global report on tuberculosis: successes, threats, and opportunities (2013) (200)
Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial (2020) (199)
Granulomatous infections: etiology and classification. (1996) (198)
Healthy Individuals That Control a Latent Infection with Mycobacterium tuberculosis Express High Levels of Th1 Cytokines and the IL-4 Antagonist IL-4δ21 (2004) (197)
Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. (2012) (197)
Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review. (2014) (192)
Severe acute respiratory syndrome vs. the Middle East respiratory syndrome (2014) (189)
Immune responses to tuberculosis in developing countries: implications for new vaccines (2005) (189)
Tuberculosis treatment and management--an update on treatment regimens, trials, new drugs, and adjunct therapies. (2015) (188)
Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. (2009) (182)
Respiratory Tract Samples, Viral Load, and Genome Fraction Yield in Patients With Middle East Respiratory Syndrome (2014) (181)
Rapid and Accurate Detection of Mycobacterium tuberculosis in Sputum Samples by Cepheid Xpert MTB/RIF Assay—A Clinical Validation Study (2011) (179)
An Observational, Laboratory-Based Study of Outbreaks of Middle East Respiratory Syndrome Coronavirus in Jeddah and Riyadh, Kingdom of Saudi Arabia, 2014 (2014) (177)
Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs. (2012) (172)
Lockdown measures in response to COVID-19 in nine sub-Saharan African countries (2020) (168)
Mass gatherings medicine: public health issues arising from mass gathering religious and sporting events (2019) (167)
Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19) (2020) (165)
Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future (2020) (161)
New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future. (2012) (160)
Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment. (2013) (156)
Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – possible lessons from a systematic review of SARS-CoV therapy (2013) (155)
The Middle East Respiratory Syndrome (MERS) (2019) (154)
Tuberculosis drug discovery in the post-post-genomic era (2014) (154)
Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections—needs, advances, and future prospects (2014) (153)
Gulf War syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile? (1997) (151)
2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation (2020) (150)
Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study. (2013) (147)
Exploring the evidence base for national and regional policy interventions to combat resistance (2016) (146)
A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death. (1999) (144)
The global emergency of tuberculosis: what is the cause? (2002) (143)
Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities (2020) (142)
Travel implications of emerging coronaviruses: SARS and MERS-CoV (2014) (142)
Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study (2014) (142)
Hepatitis C: global epidemiology and strategies for control. (2016) (141)
Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count (2005) (141)
Clinical Utility of a Commercial LAM-ELISA Assay for TB Diagnosis in HIV-Infected Patients Using Urine and Sputum Samples (2010) (141)
Totally drug‐resistant tuberculosis and adjunct therapies (2015) (139)
Progress towards improved tuberculosis diagnostics for developing countries (2006) (138)
Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action (2010) (137)
Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial (2021) (133)
Middle East respiratory syndrome (2020) (132)
Emerging infectious diseases and pandemic potential: status quo and reducing risk of global spread (2014) (127)
Diagnosis of extrapulmonary tuberculosis using the Xpert® MTB/RIF assay (2012) (124)
Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases (2020) (123)
Limiting the spread of COVID-19 in Africa: one size mitigation strategies do not fit all countries (2020) (122)
The resurgence of disease: social and historical perspectives on the 'new' tuberculosis. (2002) (120)
Passengers' destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America (2020) (118)
Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients (2007) (116)
Tuberculosis (2011) (115)
The immune system of children: the key to understanding SARS-CoV-2 susceptibility? (2020) (113)
MDR/XDR-TB management of patients and contacts: challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network. (2020) (113)
Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments (2010) (112)
Rapid diagnosis of tuberculosis through the detection of mycobacterial DNA in urine by nucleic acid amplification methods. (2009) (112)
Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis (2010) (111)
Barriers and facilitators to the uptake of tuberculosis diagnostic and treatment services by hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic review of qualitative literature. (2017) (110)
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts (2021) (110)
Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial. (2014) (109)
Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial (2008) (105)
Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings (2020) (104)
Towards host-directed therapies for tuberculosis (2015) (104)
Surveillance for emerging respiratory viruses (2014) (102)
Inflammation and tuberculosis: host‐directed therapies (2015) (102)
Anti-PD-1/PD-L1 therapy for infectious diseases: learning from the cancer paradigm. (2017) (102)
Monkeypox — Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era (2018) (98)
Utility of quantitative T-cell responses versus unstimulated interferon-γ for the diagnosis of pleural tuberculosis (2009) (97)
Monkeypox outbreaks outside endemic regions: scientific and social priorities (2022) (96)
Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis (2015) (96)
Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options (2014) (94)
Community Case Clusters of Middle East Respiratory Syndrome Coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: A Descriptive Genomic study (2014) (93)
Interaction between HIV and Mycobacterium tuberculosis: HIV-1-induced CD4 T-cell depletion and the development of active tuberculosis (2012) (91)
Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial. (2014) (91)
Thoracic Empyema: A 12-Year Study from a UK Tertiary Cardiothoracic Referral Centre (2012) (91)
Spread of MERS to South Korea and China (2015) (90)
Treatment of tuberculosis: present status and future prospects. (2005) (90)
Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB (2016) (87)
Tuberculosis -A comprehensive Clinical reference (2009) (87)
Deaths due to respiratory tract infections in Africa: a review of autopsy studies (2013) (85)
Taking forward a ‘One Health’ approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential (2016) (85)
Review of multidrug‐resistant and extensively drug‐resistant TB: global perspectives with a focus on sub‐Saharan Africa (2010) (84)
Clinical Diagnostic Utility of IP-10 and LAM Antigen Levels for the Diagnosis of Tuberculous Pleural Effusions in a High Burden Setting (2009) (83)
Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting? (2005) (83)
Biomarkers for tuberculosis disease status and diagnosis (2009) (81)
Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome (2020) (81)
Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial (1999) (81)
New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis (2011) (81)
Burden of tuberculosis at post mortem in inpatients at a tertiary referral centre in sub-Saharan Africa: a prospective descriptive autopsy study. (2015) (81)
Immune responses during COVID-19 infection (2020) (81)
COVID-19—Zoonosis or Emerging Infectious Disease? (2020) (80)
Blood kinetics of Ebola virus in survivors and nonsurvivors. (2015) (79)
Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic. (2012) (79)
London 2012 Olympic and Paralympic Games: public health surveillance and epidemiology (2014) (78)
Infection control and MERS-CoV in health-care workers (2014) (78)
Classifying new anti-tuberculosis drugs: rationale and future perspectives. (2017) (78)
Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children (2007) (77)
Epidemic and pandemic viral infections: impact on tuberculosis and the lung (2020) (77)
Coronaviruses: severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus in travelers (2014) (76)
Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infected African patients (2003) (76)
Progress and challenges in childhood tuberculosis. (2013) (76)
Seroprevalence of human immunodeficiency virus type 1 infection in Zambian children with tuberculosis (1993) (75)
Superantigens, T cells, and microbes. (1992) (75)
Tuberculosis in prisons in sub-Saharan Africa--the need for improved health services, surveillance and control. (2011) (75)
Increased expression of mRNA encoding interleukin (IL)‐4 and its splice variant IL‐4δ2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation (2004) (75)
Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB (2016) (75)
Educational outreach to promote screening for tuberculosis in primary care: a cluster randomised controlled trial (2007) (74)
Why healthcare workers are sick of TB. (2015) (73)
Adjunct immunotherapies for tuberculosis. (2012) (73)
Respiratory tract infections during the annual Hajj: potential risks and mitigation strategies (2013) (73)
Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo (2020) (72)
Cutaneous hypersensitivity reactions due to thiacetazone in the treatment of tuberculosis in Zambian children infected with HIV-I. (1993) (72)
Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population. (2010) (72)
Tuberculosis Comorbidity with Communicable and Noncommunicable Diseases. (2015) (72)
Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial (2002) (71)
Etiology, Antibiotic Resistance and Risk Factors for Neonatal Sepsis in a Large Referral Center in Zambia (2016) (71)
Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis (2009) (70)
Perspectives on tuberculosis in pregnancy. (2015) (70)
High rates of congenital cytomegalovirus infection linked with maternal HIV infection among neonatal admissions at a large referral center in sub-Saharan Africa. (2014) (70)
The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB (2022) (70)
COVID-19 and malaria: A symptom screening challenge for malaria endemic countries (2020) (69)
Extensively drug-resistant tuberculosis: epidemiology and management challenges. (2010) (69)
Risk factors associated with pulmonary tuberculosis: smoking, diabetes and anti-TNFα drugs. (2012) (69)
The Prevalence of Tuberculosis in Zambia: Results from the First National TB Prevalence Survey, 2013–2014 (2016) (69)
Faster for less: the new “shorter” regimen for multidrug-resistant tuberculosis (2016) (69)
Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak (2020) (69)
Effectiveness of interventions for diagnosis and treatment of tuberculosis in hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic review. (2017) (67)
Interpretation of Mycobacterium tuberculosis antigen-specific IFN-gamma release assays (T-SPOT.TB) and factors that may modulate test results. (2007) (67)
Recent developments in the diagnosis and management of tuberculosis (2016) (66)
Addressing challenges to rolling out COVID-19 vaccines in African countries (2021) (66)
Innovative trial designs are practical solutions for improving the treatment of tuberculosis. (2012) (66)
Use of dried whole blood spots to measure CD4+ lymphocyte counts in HIV-1-infected patients (2003) (66)
Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines. (2015) (66)
Necropsies in African children: consent dilemmas for parents and guardians (2001) (66)
An Inflammatory Profile Correlates With Decreased Frequency of Cytotoxic Cells in Coronavirus Disease 2019 (2020) (64)
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1 (2021) (64)
Effect of sample handling on analysis of cytokine responses to Mycobacterium tuberculosis in clinical samples using ELISA, ELISPOT and quantitative PCR. (2005) (64)
Evaluation of the Burden of Unsuspected Pulmonary Tuberculosis and Co-Morbidity with Non-Communicable Diseases in Sputum Producing Adult Inpatients (2012) (64)
In Vivo and In Vitro Studies of a Novel Cytokine, Interleukin 4δ2, in Pulmonary Tuberculosis (2005) (63)
Ex Vivo Cytokine mRNA Levels Correlate with Changing Clinical Status of Ethiopian TB Patients and their Contacts Over Time (2008) (63)
Viral Hepatitis: Etiology, Epidemiology, Transmission, Diagnostics, Treatment, and Prevention. (2019) (63)
Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis (2016) (63)
Tuberculosis in the UK—time to regain control (2011) (63)
Clinical Aspects of Adult Tuberculosis. (2015) (63)
Role of fluorine 18 fluorodeoxyglucose positron emission tomography-computed tomography in focal and generalized infectious and inflammatory disorders. (2012) (62)
Tuberculosis Trends in Saudis and Non-Saudis in the Kingdom of Saudi Arabia – A 10 Year Retrospective Study (2000–2009) (2012) (62)
Safety and immunogenicity of a five-dose series of inactivated Mycobacterium vaccae vaccination for the prevention of HIV-associated tuberculosis. (2000) (61)
Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions (2016) (61)
Impact of the human immunodeficiency virus type-1 on common pediatric illnesses in Zambia. (1995) (61)
Tuberculosis in association with HIV/AIDS emerges as a major nonobstetric cause of maternal mortality in Sub‐Saharan Africa (2010) (61)
Viewpoint: Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection (2011) (60)
Paradox of the global emergency of tuberculosis (1999) (60)
Human immunodeficiency virus type-1 infection in Zambian children with tuberculosis: changing seroprevalence and evaluation of a thioacetazone-free regimen. (1994) (60)
B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis (2015) (59)
2019-nCoV in context: lessons learned? (2020) (59)
New tuberculosis diagnostics and rollout. (2015) (58)
Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action. (2013) (58)
Pathogens, prejudice, and politics: the role of the global health community in the European refugee crisis (2016) (58)
CURRENT CONCEPTS Tuberculosis (2013) (57)
Chikungunya: Epidemiology, Pathogenesis, Clinical Features, Management, and Prevention. (2019) (57)
Epidemiology of Antituberculosis Drug Resistance in Saudi Arabia: Findings of the First National Survey (2013) (57)
Urogenital tuberculosis — epidemiology, pathogenesis and clinical features (2019) (57)
Advancing the development of tuberculosis therapy (2012) (57)
Preventing the spread of multidrug-resistant tuberculosis and protecting contacts of infectious cases. (2017) (56)
Manson's Tropical Diseases, 21st Edition (2003) (56)
HIV Case Notification Rates in the Kingdom of Saudi Arabia over the Past Decade (2000–2009) (2012) (55)
Toning down the 2019-nCoV media hype—and restoring hope (2020) (55)
Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review (2017) (55)
The return of the white plague: global poverty and the 'new' tuberculosis. (2003) (55)
Modulation of Cell Death by M. tuberculosis as a Strategy for Pathogen Survival (2011) (55)
The Global Health Security index and Joint External Evaluation score for health preparedness are not correlated with countries' COVID-19 detection response time and mortality outcome (2020) (54)
FOXP3 gene expression in a tuberculosis case contact study (2007) (54)
Emerging viral respiratory tract infections—environmental risk factors and transmission (2014) (54)
Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis (2021) (54)
COVID-19: viral–host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection (2020) (54)
Host-directed therapies for improving poor treatment outcomes associated with the middle east respiratory syndrome coronavirus infections (2015) (54)
COVID-19: viral–host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection (2020) (54)
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 (2022) (54)
World TB Day 2014: finding the missing 3 million (2014) (53)
Myobacterium tuberculosis Induces Selective Up-Regulation of TLRs in the Mononuclear Leukocytes of Patients with Active Pulmonary Tuberculosis1 (2006) (53)
The Late Arrival of Coronavirus Disease 2019 (COVID-19) in Africa: Mitigating Pan-continental Spread (2020) (53)
Tuberculosis in disadvantaged groups (2001) (52)
HEp-2 cell-adherent Escherichia coli in patients with human immunodeficiency virus-associated diarrhea. (1995) (52)
Enzootic patterns of Middle East respiratory syndrome coronavirus in imported African and local Arabian dromedary camels: a prospective genomic study (2019) (52)
Toxoplasma serology in Zambian and Ugandan patients infected with the human immunodeficiency virus. (1991) (52)
Evaluation of PCR-based methods for the diagnosis of tuberculosis by identification of mycobacterial DNA in urine samples. (2002) (51)
Tuberculosis in prisons: anatomy of global neglect (2011) (51)
Tuberculosis and tuberculosis/HIV/AIDS-associated mortality in Africa: the urgent need to expand and invest in routine and research autopsies. (2012) (51)
Comparison of a Clinical Prediction Rule and a LAM Antigen-Detection Assay for the Rapid Diagnosis of TBM in a High HIV Prevalence Setting (2010) (51)
Rapid nucleic acid diagnostics for the detection of antimicrobial resistance in Gram-negative bacteria: is it time for a paradigm shift? (2014) (51)
Thoracic empyema: current opinions in medical and surgical management (2010) (50)
Radiological features of pulmonary tuberculosis in 963 HIV-infected adults at three Central African Hospitals. (1997) (50)
Four-year study of abdominal ultrasound in 900 Central African adults with AIDS referred for diagnostic imaging (2000) (49)
Middle East Respiratory Syndrome– advancing the public health and research agenda on MERS- lessons from the South Korea outbreak (2015) (49)
Mycotic aneurysms: a case report, clinical review and novel imaging strategy. (2012) (49)
Performance of urine lipoarabinomannan assays for paediatric tuberculosis in Tanzania (2015) (49)
Nonsteroidal antiinflammatory drugs for adjunctive tuberculosis treatment. (2013) (49)
The cursed duet today: Tuberculosis and HIV-coinfection. (2017) (48)
Tuberculosis: A Comprehensive Clinical Reference (2009) (48)
Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection (2016) (48)
Pattern of adult malignancies in Zambia (1980-1989) in light of the human immunodeficiency virus type 1 epidemic. (1995) (48)
Biomarkers for risk of developing active tuberculosis in contacts of TB patients: a prospective cohort study (2015) (47)
Implications of Storing Urinary DNA from Different Populations for Molecular Analyses (2009) (47)
Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa? (2015) (46)
Prevalence and risk factors for betaherpesvirus DNAemia in children >3 weeks and <2 years of age admitted to a large referral hospital in sub-Saharan Africa. (2014) (46)
Short-term economic impact of the Zika virus outbreak. (2016) (46)
Infectious diseases epidemic threats and mass gatherings: refocusing global attention on the continuing spread of the Middle East Respiratory syndrome coronavirus (MERS-CoV) (2016) (46)
The global dynamics of diabetes and tuberculosis: the impact of migration and policy implications. (2017) (46)
Antimicrobial resistance preparedness in sub-Saharan African countries (2020) (46)
The impact of social factors on tuberculosis management. (2007) (46)
Immune systems in developed and developing countries; implications for the design of vaccines that will work where BCG does not. (2006) (45)
The 6-Kilodalton Early Secreted Antigenic Target-Responsive, Asymptomatic Contacts of Tuberculosis Patients Express Elevated Levels of Interleukin-4 and Reduced Levels of Gamma Interferon (2006) (45)
Increased cortisol: cortisone ratio in acute pulmonary tuberculosis. (2000) (45)
Impact of infectious disease epidemics on tuberculosis diagnostic, management, and prevention services: experiences and lessons from the 2014–2015 Ebola virus disease outbreak in West Africa (2016) (44)
Agents of change: The role of healthcare workers in the prevention of nosocomial and occupational tuberculosis. (2017) (44)
Variation in Gamma Interferon Responses to Different Infecting Strains of Mycobacterium tuberculosis in Acid-Fast Bacillus Smear-Positive Patients and Household Contacts in Antananarivo, Madagascar (2010) (44)
Tackling the tuberculosis epidemic in sub-Saharan Africa--unique opportunities arising from the second European Developing Countries Clinical Trials Partnership (EDCTP) programme 2015-2024. (2015) (44)
Extensively drug‐resistant tuberculosis (XDR‐TB) among health care workers in South Africa (2010) (44)
Advances in the immunopathogenesis of pulmonary tuberculosis (2001) (43)
Applicability of the shorter 'Bangladesh regimen' in high multidrug-resistant tuberculosis settings. (2016) (43)
New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis (2018) (43)
Multidrug-resistant tuberculosis--can the tide be turned? (2001) (42)
Tuberculosis: amplification-based clinical diagnostic techniques. (2003) (42)
Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants (2020) (42)
Local Regulation of Glucocorticoid Activity in Sites of Inflammation: Insights from the Study of Tuberculosis (2000) (41)
From Easing Lockdowns to Scaling-Up Community-Based COVID-19 Screening, Testing, and Contact Tracing in Africa - Shared Approaches, Innovations, and Challenges to Minimize Morbidity and Mortality. (2020) (41)
Increased outbreaks of monkeypox highlight gaps in actual disease burden in Sub-Saharan Africa and in animal reservoirs (2022) (41)
Intestinal parasites in HIV-seropositive Zambian children with diarrhoea. (1995) (41)
Lassa Fever: Epidemiology, Clinical Features, Diagnosis, Management and Prevention. (2019) (41)
Vaccination for monkeypox prevention in persons with high-risk sexual behaviours to control on-going outbreak of monkeypox virus clade 3. (2022) (41)
The annual Hajj pilgrimage—minimizing the risk of ill health in pilgrims from Europe and opportunity for driving the best prevention and health promotion guidelines (2016) (40)
A large ongoing outbreak of hepatitis A predominantly affecting young males in Lazio, Italy; August 2016 - March 2017 (2017) (40)
Post-caesarean section surgical site infections at a Tanzanian tertiary hospital: a prospective observational study. (2016) (40)
T-Cell Therapy: Options for Infectious Diseases (2015) (40)
COVID-19 and tuberculosis-threats and opportunities. (2020) (39)
Active screening and surveillance in the United Kingdom for Middle East respiratory syndrome coronavirus in returning travellers and pilgrims from the Middle East: a prospective descriptive study for the period 2013–2015 (2016) (39)
COVID-19 and tuberculosis-threats and opportunities. (2020) (39)
Reflections on the white plague. (2009) (38)
Burden of respiratory tract infections at post mortem in Zambian children (2016) (38)
Contact Tracing and the COVID-19 Response in Africa: Best Practices, Key Challenges, and Lessons Learned from Nigeria, Rwanda, South Africa, and Uganda (2021) (38)
Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy — Achieving global consensus and visibility for cellular host-directed therapies (2020) (38)
Gene expression of IL17 and IL23 in the lungs of patients with active tuberculosis (2008) (38)
Towards the development of EU/EEA Standards for Tuberculosis Care (ESTC) (2011) (37)
COVID‐19 and renin‐angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) ‐ Is there any scientific evidence for controversy? (2020) (37)
Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review (2021) (37)
Infection and disease caused by environmental mycobacteria (2002) (37)
The Middle East Respiratory Syndrome Coronavirus – A Continuing Risk to Global Health Security (2016) (36)
Interferon gamma assays for tuberculosis. (2005) (36)
Aetiology of hospital-acquired pneumonia and trends in antimicrobial resistance (2014) (36)
An assessment of air as a source of DNA contamination encountered when performing PCR. (2009) (36)
Trends of Zambia’s tuberculosis burden over the past two decades (2011) (36)
Host-Directed Therapies for Tackling Multi-Drug Resistant Tuberculosis: Learning From the Pasteur-Bechamp Debates. (2015) (35)
Trials and tribulations of an African‐led research and capacity development programme: the case for EDCTP investments (2010) (35)
Expression of a novel cytokine, IL-4delta2, in HIV and HIV–tuberculosis co-infection (2005) (35)
Reducing risks to health and wellbeing at mass gatherings: the role of the Sendai Framework for Disaster Risk Reduction (2016) (35)
Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis. (2016) (35)
In vivo and in vitro studies of a novel cytokine, interleukin 4delta2, in pulmonary tuberculosis. (2005) (35)
Responding to the Challenge of the Dual COVID-19 and Ebola Epidemics in the Democratic Republic of Congo—Priorities for Achieving Control (2020) (35)
Vitamin D as Adjunctive Host-Directed Therapy in Tuberculosis: A Systematic Review (2016) (34)
Intravenous immunoglobulin (IVIg) for refractory and difficult-to-treat infections. (2012) (34)
Surgical treatment of complications of pulmonary tuberculosis, including drug-resistant tuberculosis. (2015) (34)
Emerging and Reemerging Infectious Diseases: Global Overview (2019) (33)
Clinical features, microbiology and surgical outcomes of infective endocarditis: a 13-year study from a UK tertiary cardiothoracic referral centre. (2015) (33)
The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security (2020) (33)
Scale‐up of TB and HIV programme collaborative activities in Zambia – a 10‐year review (2012) (32)
Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy. (2017) (32)
Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries (2022) (32)
The relentless spread of tuberculosis in Zambia--trends over the past 37 years (1964-2000). (2003) (32)
Controversies and unresolved issues in tuberculosis prevention and control: a low-burden-country perspective. (2012) (32)
Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis (2018) (32)
The white plague returns to London—with a vengeance (2011) (32)
Intestinal secretory IgA immune response against human immunodeficiency virus among infected patients with acute and chronic diarrhea. (1994) (32)
COVID-19: viral–host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection (2020) (32)
The tuberculosis pandemic: implications for health in the tropics. (1999) (31)
COVID-19 disease—Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study (2020) (31)
Expression of apoptosis‐related genes in an Ethiopian cohort study correlates with tuberculosis clinical status (2009) (31)
The Global Case-Fatality Rate of COVID-19 Has Been Declining Since May 2020 (2021) (31)
The tuberculosis pandemic--which way now? (1999) (30)
Advancing the portfolio of tuberculosis diagnostics, drugs, biomarkers, and vaccines. (2014) (30)
Rapid infectious diseases diagnostics using Smartphones. (2015) (30)
Immunometabolism: new insights and lessons from antigen-directed cellular immune responses (2020) (30)
Artemisia Spp. Derivatives for COVID-19 Treatment: Anecdotal Use, Political Hype, Treatment Potential, Challenges, and Road Map to Randomized Clinical Trials (2020) (30)
Artemisia Spp. Derivatives for COVID-19 Treatment: Anecdotal Use, Political Hype, Treatment Potential, Challenges, and Road Map to Randomized Clinical Trials (2020) (30)
Emerging respiratory tract viral infections (2015) (30)
Advances in multiparametric molecular diagnostics technologies for respiratory tract infections (2013) (30)
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019 (2022) (29)
The social context of tuberculosis treatment in urban risk groups in the United Kingdom: a qualitative interview study. (2015) (29)
Tuberculosis due to high-dose challenge in partially immune individuals: a problem for vaccination? (2009) (29)
Cellular therapy in tuberculosis. (2015) (29)
The experience of postnatal depression in South Asian mothers living in Great Britain: a qualitative study (2011) (29)
Historical declines in tuberculosis: nature, nurture and the biosocial model. (2001) (28)
Association of rotavirus and human immunodeficiency virus infection in children hospitalized with acute diarrhea, Lusaka, Zambia. (1994) (28)
Euro 2012 European Football Championship Finals: planning for a health legacy (2014) (28)
The neglected global burden of tuberculosis in pregnancy. (2014) (28)
Transmission of respiratory tract infections at mass gathering events. (2020) (28)
Human Zika infection induces a reduction of IFN-γ producing CD4 T-cells and a parallel expansion of effector Vδ2 T-cells (2017) (28)
MANSON'S TROPICAL DISEASES (1973) (28)
Evaluation of the efficacy of valproic acid and suberoylanilide hydroxamic acid (vorinostat) in enhancing the effects of first-line tuberculosis drugs against intracellular Mycobacterium tuberculosis. (2018) (28)
COVID-19 travel restrictions and the International Health Regulations – Call for an open debate on easing of travel restrictions (2020) (27)
Tuberculosis and the poverty-disease cycle (1999) (27)
Population differences in death rates in HIV-positive patients with tuberculosis. (2007) (27)
Mass gatherings medicine: international cooperation and progress (2014) (27)
The immunological footprint of Mycobacterium tuberculosis T-cell epitope recognition. (2012) (27)
Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosis (2011) (27)
The historic and unprecedented United Nations General Assembly High Level Meeting on Tuberculosis (UNGA-HLM-TB)-'United to End TB: An Urgent Global Response to a Global Epidemic'. (2018) (27)
Middle East respiratory syndrome coronavirus: epidemic potential or a storm in a teacup? (2014) (27)
Analogies and metaphors in clinical medicine. (2012) (27)
T cell receptor expression in Sjögren's syndrome. (1991) (27)
The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients (2021) (26)
Latent TB Infection (LTBI) - Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battleground. (2019) (26)
Usefulness of bronchoalveolar lavage in the management of patients presenting with lung infiltrates and suspect COVID-19-associated pneumonia: A case report (2020) (26)
Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic (2021) (26)
Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic (2021) (26)
Science, medicine, and the future: Tuberculosis (1998) (26)
Shifting from tuberculosis control to elimination: Where are we? What are the variables and limitations? Is it achievable? (2017) (26)
Dysgonic Fermenter-type 2: an emerging zoonosis. Report of two cases and review. (1988) (26)
Human Coronavirus Infections—Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and SARS-CoV-2 (2020) (26)
Minimizing the impact of the triple burden of COVID-19, tuberculosis and HIV on health services in sub-Saharan Africa (2021) (26)
A Broad Profile of Co-Dominant Epitopes Shapes the Peripheral Mycobacterium tuberculosis Specific CD8+ T-Cell Immune Response in South African Patients with Active Tuberculosis (2013) (26)
Delamanid expanded access novel treatment of drug resistant tuberculosis (2015) (26)
'Sample-in, answer-out'? Evaluation and comprehensive analysis of the Unyvero P50 pneumonia assay. (2016) (25)
Multidrug‐resistant TB in Zambia: review of national data from 2000 to 2011 (2013) (25)
Advancing Priority Research on the Middle East Respiratory Syndrome Coronavirus (2013) (25)
From Easing Lockdowns to Scaling Up Community-based Coronavirus Disease 2019 Screening, Testing, and Contact Tracing in Africa—Shared Approaches, Innovations, and Challenges to Minimize Morbidity and Mortality (2020) (25)
‘Complex’ but coping: experience of symptoms of tuberculosis and health care seeking behaviours - a qualitative interview study of urban risk groups, London, UK (2014) (25)
Middle East Respiratory Syndrome Corona virus, MERS-CoV. Conclusions from the 2nd Scientific Advisory Board Meeting of the WHO Collaborating Center for Mass Gathering Medicine, Riyadh (2014) (24)
First COVID-19 case in Zambia — Comparative phylogenomic analyses of SARS-CoV-2 detected in African countries (2020) (24)
Mobile Health Technology for Enhancing the COVID-19 Response in Africa: A Potential Game Changer? (2020) (24)
Biomarkers of disease activity, cure, and relapse in tuberculosis. (2009) (24)
Towards more accurate 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) imaging in Active and Latent Tuberculosis. (2020) (24)
Establishing a new service role in tuberculosis care: the tuberculosis link worker. (2008) (24)
Use of the Xpert® MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia (2013) (24)
Performance of the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed, paraffin-embedded tissues (2017) (23)
Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019 (2021) (23)
Tuberculosis and mass gatherings-opportunities for defining burden, transmission risk, and the optimal surveillance, prevention, and control measures at the annual Hajj pilgrimage. (2016) (23)
World TB Day 2017: Advances, Challenges and Opportunities in the "End-TB" Era. (2017) (23)
Improving treatment outcomes for MDR-TB - Novel host-directed therapies and personalised medicine of the future. (2019) (23)
Doing something about tuberculosis (1999) (23)
Studies of a common idiotype PR4 in autoimmune rheumatic disease. (1988) (23)
Peptide microarray-based characterization of antibody responses to host proteins after bacille Calmette-Guérin vaccination. (2017) (22)
The stability of mRNA encoding IL-4 is increased in pulmonary tuberculosis, while stability of mRNA encoding the antagonistic splice variant, IL-4delta2, is not. (2007) (22)
Rational development of adjunct immune-based therapies for drug-resistant tuberculosis: hypotheses and experimental designs. (2012) (22)
Accelerating the development of therapeutic strategies for drug-resistant tuberculosis (2018) (22)
Tuberculin skin test - Outdated or still useful for Latent TB infection screening? (2019) (22)
European policies in the management of tuberculosis among migrants. (2017) (22)
Investing in improved performance of national tuberculosis programs reduces the tuberculosis burden: analysis of 22 high-burden countries, 2002-2009. (2012) (22)
SeekTB, a Two-Stage Multiplex Real-Time-PCR-Based Method for Differentiation of the Mycobacterium tuberculosis Complex (2012) (22)
Impact of the Xpert MTB/RIF diagnostic test for tuberculosis in countries with a high burden of disease (2015) (22)
Ebola Virus Disease: Epidemiology, Clinical Features, Management, and Prevention. (2019) (22)
Tackling the spread of drug-resistant tuberculosis in Europe (2012) (22)
Tuberculosis, steroid metabolism and immunity (1996) (22)
Tuberculosis in prisons in sub-Saharan Africa--a potential time bomb. (2011) (22)
Drug-resistant tuberculosis in the European Union: opportunities and challenges for control. (2010) (21)
The colliding epidemics of COVID-19, Ebola, and measles in the Democratic Republic of the Congo (2020) (21)
Viral Hemorrhagic Fevers Other than Ebola and Lassa. (2019) (21)
Neuropathology and Inflammatory Cell Characterization in 10 Autoptic COVID-19 Brains (2021) (21)
A sustainable agenda for tuberculosis control and research (2012) (21)
Latent tuberculosis infection: diagnostic tests and when to treat. (2019) (21)
Translating the Tuberculosis Research Agenda: Much Accomplished, but Much More to Be Done. (2015) (21)
Multidrug and Extensively Drug-resistant Tuberculosis: Epidemiology, Clinical Features, Management and Treatment. (2019) (21)
Tuberculosis, HIV/AIDS and Malaria Health Services in sub-Saharan Africa – A Situation Analysis of the Disruptions and Impact of the COVID-19 Pandemic (2022) (21)
Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019 (2022) (21)
The development, evaluation and performance of molecular diagnostics for detection of Mycobacterium tuberculosis (2016) (20)
Tuberculosis eradication versus control. (2017) (20)
Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019 (2021) (20)
Trained Immunity for Personalized Cancer Immunotherapy: Current Knowledge and Future Opportunities (2020) (20)
Immunologic aspects of tropical lung disease. (2002) (20)
Making DOTS succeed (1997) (20)
Mitigating the effect of the COVID-19 pandemic on sickle cell disease services in African countries (2020) (20)
Combined PET and X-ray computed tomography imaging in pulmonary infections and inflammation (2011) (20)
Trends in childhood tuberculosis in Zambia: a situation analysis. (2013) (20)
COVID-19 and the scaled-down 2020 Hajj Pilgrimage—Decisive, logical and prudent decision making by Saudi authorities overcomes pre-Hajj public health concerns (2020) (19)
Zika virus outbreak and the case for building effective and sustainable rapid diagnostics laboratory capacity globally (2016) (19)
Immunometabolism and Pulmonary Infections: Implications for Protective Immune Responses and Host-Directed Therapies (2019) (19)
Frequency of Mycobacterium tuberculosis-specific CD8+ T-cells in the course of anti-tuberculosis treatment. (2015) (19)
Mass gatherings medicine and global health security (2012) (19)
Identification of Pneumocystis carinii DNA by polymerase chain reaction in necropsy lung samples from children dying of respiratory tract illnesses. (2002) (19)
Undiagnosed Active Pulmonary Tuberculosis among Pilgrims during the 2015 Hajj Mass Gathering: A Prospective Cross-sectional Study. (2017) (19)
A risk-based approach is best for decision making on holding mass gathering events (2020) (19)
Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay (2020) (19)
What is the experience from previous mass gathering events? Lessons for Zika virus and the Olympics 2016 (2016) (19)
Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB study (2018) (19)
Health systems in the Republic of Congo: challenges and opportunities for implementing tuberculosis and HIV collaborative service, research, and training activities. (2017) (18)
Handbook of tuberculosis (2009) (18)
Eliminating tuberculosis and tuberculosis-HIV co-disease in the 21st century: key perspectives, controversies, unresolved issues, and needs. (2012) (18)
Feasibility and Diagnostic Utility of Antigen-Specific Interferon-γ Responses for Rapid Immunodiagnosis of Tuberculosis Using Induced Sputum (2010) (18)
Nosocomial outbreak of the Middle East Respiratory Syndrome coronavirus: A phylogenetic, epidemiological, clinical and infection control analysis (2020) (18)
Tuberculosis control is crucial to achieve the MDGs (2010) (18)
Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 (2022) (18)
Zero deaths from tuberculosis: progress, reality, and hope. (2013) (18)
PET/CT features of extrapulmonary tuberculosis at first clinical presentation: a cross-sectional observational 18F-FDG imaging study across six countries (2019) (18)
Childhood Tuberculosis and Infection with the Human Immunodeficiency Virus (1995) (18)
Human monoclonal antibodies to phenolic glycolipid-I derived from patients with leprosy, and production of specific anti-idiotypes. (1988) (17)
Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis (2017) (17)
Salmonella septic arthritis. (1991) (17)
Ending the Global Tuberculosis Epidemic by 2030 - The Moscow Declaration and achieving a Major Translational Change in Delivery of TB Healthcare. (2017) (17)
Effect of SARS-CoV-2 Infection in Pregnancy on Maternal and Neonatal Outcomes in Africa: An AFREhealth Call for Evidence through Multicountry Research Collaboration (2020) (17)
Nucleic acid detection and quantification in the developing world. (2009) (17)
The Hajj pilgrimage and surveillance for Middle East Respiratory syndrome coronavirus in pilgrims from African countries (2014) (17)
The critically ill patient with tuberculosis in intensive care: Clinical presentations, management and infection control (2018) (17)
Within-Subject Variability and Boosting of T-Cell IFN-gamma Responses Following Tuberculin Skin Testing (2009) (17)
Drugs for neglected diseases. (2002) (17)
Hosting of mass gathering sporting events during the 2013–2016 Ebola virus outbreak in West Africa: experience from three African countries (2016) (17)
Effect of Mycobacterium vaccae (SRL172) immunotherapy on radiographic healing in tuberculosis. (2004) (17)
Reversing the tide of the UK tuberculosis epidemic (2013) (17)
How great is the risk of Middle East respiratory syndrome coronavirus to the global population? (2013) (17)
Taking forward the World TB Day 2016 theme ‘Unite to End Tuberculosis’ for the WHO Africa Region (2016) (16)
Vaccine against Middle East respiratory syndrome coronavirus (2019) (16)
Exposed, but Not Protected: More Is Needed to Prevent Drug-Resistant Tuberculosis in Healthcare Workers and Students. (2016) (16)
Eosinophilia in the returning traveler. (2012) (16)
Pattern recognition and cellular immune responses to novel Mycobacterium tuberculosis-antigens in individuals from Belarus (2012) (16)
Human immunodeficiency virus-associated diarrhea and wasting in Zambia: selected risk factors and clinical associations. (1998) (16)
Advancing global tuberculosis control after the UNGA-HLM (2018) (16)
Strong anti-Epstein Barr virus (EBV) or cytomegalovirus (CMV) cellular immune responses predict survival and a favourable response to anti-tuberculosis therapy. (2017) (16)
Smoking is not beneficial for tuberculosis. (2004) (16)
Programmatic versus personalised approaches to managing the global epidemic of multidrug-resistant tuberculosis. (2020) (15)
Emerging respiratory tract infections (2014) (15)
Establishing a united front against the injustice of tuberculosis. (1998) (15)
Use of saliva as an alternative to serum for HIV screening in Africa. (1995) (15)
Detection and characterization of carbapenem resistant Gram‐negative bacilli isolates recovered from hospitalized patients at Soba University Hospital, Sudan (2020) (15)
Chikungunya (2018) (15)
Differential cellular recognition pattern to M. tuberculosis targets defined by IFN-γ and IL-17 production in blood from TB + patients from Honduras as compared to health care workers: TB and immune responses in patients from Honduras (2013) (15)
Post TB treatment infectious complications. (2020) (15)
Gut parasites in HIV-seropositive Zambian adults with diarrhoea. (1994) (15)
BCG: the story continues (2005) (14)
Effects of disruption from COVID-19 on antimalarial strategies (2020) (14)
Joint TDR/EC expert consultation on biomarkers in tuberculosis (2008) (14)
Recovering from the Impact of the Covid-19 Pandemic and Accelerating to Achieving the United Nations General Assembly Tuberculosis Targets (2021) (14)
The spectrum of African Kaposi's sarcoma: is it consequential upon diverse immunological responses? (1996) (14)
Implementation and Operational Research: Clinical Impact of the Xpert MTB/RIF Assay in Patients With Multidrug-Resistant Tuberculosis (2016) (14)
Middle East Respiratory Syndrome - need for increased vigilance and watchful surveillance for MERS-CoV in sub-Saharan Africa (2015) (14)
Chemotherapy and immunity in opportunistic parasitic infections in AIDS (1992) (14)
Co-expression of human T cell receptor chains with mouse CD3 on the cell surface of a mouse T cell hybridoma. (1992) (14)
Relationship Between Viremia and Specific Organ Damage in Ebola Patients: A Cohort Study (2018) (14)
Ethics of healthcare research in developing countries. (2002) (13)
Non-tuberculous mycobacterial pulmonary infections. (2002) (13)
Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials. (2019) (13)
Host-directed therapies for multidrug resistant tuberculosis (2016) (13)
Middle East respiratory syndrome in the shadow of Ebola (2015) (13)
Aiming for zero tuberculosis transmission in low-burden countries. (2017) (13)
Taking forward the Stop TB Partnership and World Health Organization Joint Theme for World TB Day March 24th 2018 - "Wanted: Leaders for a TB-Free World. You can make history. End TB". (2018) (13)
Mycobacterium tuberculosis-specific and MHC class I-restricted CD8+ T-cells exhibit a stem cell precursor-like phenotype in patients with active pulmonary tuberculosis. (2015) (13)
Advancing accurate metrics for future pandemic preparedness (2022) (13)
De-isolation of patients with pulmonary tuberculosis after start of treatment - clear, unequivocal guidelines are missing. (2017) (13)
Host-directed therapies for antimicrobial resistant respiratory tract infections (2016) (13)
Xpert MTB/RIF test for tuberculosis (2011) (13)
The changing treatment landscape for MDR/XDR-TB - Can current clinical trials revolutionise and inform a brave new world? (2019) (13)
The Critical Need for Pooled Data on COVID-19 in African Children: An AFREhealth Call for Action through Multi-Country Research Collaboration (2021) (12)
Efficacy and Safety of ‘Fixed Dose’ versus ‘Loose’ Drug Regimens for Treatment of Pulmonary Tuberculosis in Two High TB-Burden African Countries: A Randomized Controlled Trial (2016) (12)
World TB Day 2022: Revamping and Reshaping Global TB Control Programs by Advancing Lessons learnt from the COVID-19 pandemic (2022) (12)
Post-mortem examination of Hospital Inpatient COVID-19 Deaths in Lusaka, Zambia - A Descriptive Whole-body Autopsy Series (2021) (12)
The effects of BCG immunization and human immunodeficiency virus infection on dual skin test reactions to purified protein derivative and Mycobacterium avium sensitin among adults in Zambia. (1999) (12)
Universal health coverage for refugees and migrants in the twenty-first century (2018) (12)
Scaling Up Covid-19 Vaccination in Africa - Lessons from the HIV Pandemic. (2021) (12)
Criteria for discharge of patients with Ebola virus diseases in high-income countries. (2015) (12)
Anti-Bovine Viral Diarrhoea Virus Antibodies in Adult Zambian Patients Infected with the Human Immunodeficiency Virus (1993) (12)
Host-directed therapies and holistic care for tuberculosis. (2020) (12)
Microbes as Master Immunomodulators: Immunopathology, Cancer and Personalized Immunotherapies (2020) (12)
The pathogen recognition sensor, NOD2, is variably expressed in patients with pulmonary tuberculosis (2007) (12)
Concrete action now: UN High-Level Meeting on Tuberculosis. (2018) (12)
Detection of Viral RNA in Tissues following Plasma Clearance from an Ebola Virus Infected Patient (2016) (12)
Spectrum of innate and adaptive immune response to SARS CoV 2 infection across asymptomatic, mild and severe cases; a longitudinal cohort study (2020) (12)
Effectiveness of service models and organisational structures supporting tuberculosis identification and management in hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic review (2018) (12)
Risk of antibiotic resistant meningococcal infections in Hajj pilgrims (2019) (12)
Leprosy trends in Zambia 1991–2009 (2012) (12)
Advances in the management of tuberculosis: clinical trials and beyond (2000) (12)
Identification of Pneumocystis carinii DNA in oropharyngeal mouth washes from AIDS children dying of respiratory illnesses. (2002) (11)
Recent advances in the development and evaluation of molecular diagnostics for Ebola virus disease (2019) (11)
After the UNGA High-Level Meeting on Tuberculosis-what next and how? (2019) (11)
Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance (2012) (11)
Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2–host interactome (2021) (11)
World TB Day 2016--advancing global tuberculosis control efforts. (2016) (11)
Bacteraemias in HIV-positive patients (1990) (11)
The biosocial dynamics of tuberculosis (2009) (11)
Zika virus in saliva-New challenges for prevention of human to human transmission. (2016) (11)
DF-2 infection. (1988) (11)
Spread of Neisseria meningitidis group A clone III-I meningitis epidemic into Zambia. (1998) (11)
Monkeypox: another test for PCR (2022) (11)
Comparison of same day versus delayed enumeration of TB-specific T cell responses. (2010) (11)
Turning the tide against tuberculosis (2006) (11)
Rapid diagnostics urgently needed for killer infections (2013) (11)
Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants (2018) (11)
Drug resistant TB - latest developments in epidemiology, diagnostics and management. (2022) (11)
Global fund financing of tuberculosis services delivery in prisons. (2012) (11)
Chloroquine and proguanil prophylaxis in travellers to Kenya (1992) (11)
Latent tuberculosis infection and renal transplantation - Diagnosis and management. (2019) (11)
Humoral immune profiling of mycobacterial antigen recognition in sarcoidosis and Löfgren's syndrome using high-content peptide microarrays. (2017) (11)
Ebola: missed opportunities for Europe-Africa research. (2015) (11)
Case Definitions for Paediatric AIDS: The Zambian Experience (1993) (11)
Lessons from the COVID-19 Pandemic—Unique Opportunities for Unifying, Revamping and Reshaping Epidemic Preparedness of Europe’s Public Health Systems (2020) (10)
Tuberculosis 2013 : 3 Tuberculosis comorbidity with communicable and non-communicable diseases : integrating health services and control eff orts (2013) (10)
A One-Health lens for anthrax (2019) (10)
Tuberculosis research and development: seeding the future. (2018) (10)
World TB Day 2016: reflections on the global TB emergency. (2016) (10)
Sequential 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) scan findings in patients with extrapulmonary tuberculosis during the course of treatment—a prospective observational study (2020) (10)
AIDS and Respiratory Medicine (1997) (10)
Tuberculosis among older adults in Zambia: burden and characteristics among a neglected group (2017) (10)
Seroprevalence and associated risk factors of Dengue fever in Kassala state, eastern Sudan (2020) (10)
Mycobacterium vaccae ( SRL 172 ) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis : a randomised placebo-controlled trial (10)
Human Cytomegalovirus (HCMV) Infection in Sub-Saharan Africa (2013) (10)
Zoonotic Tuberculosis – The Changing Landscape (2021) (10)
Applying lessons from SARS to a newly identified coronavirus (2013) (10)
T cell receptor usage in patients with non‐progressing HIV infection (2002) (10)
Chikungunya Outbreak in the Republic of the Congo, 2019—Epidemiological, Virological and Entomological Findings of a South-North Multidisciplinary Taskforce Investigation (2020) (10)
Biomarkers for tuberculosis disease activity, cure, and relapse. (2010) (10)
Learning from epidemiological, clinical, and immunological studies on Mycobacterium africanum for improving current understanding of host-pathogen interactions, and for the development and evaluation of diagnostics, host-directed therapies, and vaccines for tuberculosis. (2017) (10)
Totally-drug-resistant tuberculosis: hype versus hope. (2014) (10)
Human monoclonal antibodies to phenolic glycolipid-1 from leprosy patients cross react with poly(ADP-ribose), polynucleotides and tissue bound antigens. (1988) (10)
Mass Religious Gatherings Events and COVID-19 -Easing of COVID-19 Restrictions and a Staged Approach to Scaling up the Umrah Pilgrimage. (2021) (10)
Sixth cranial nerve palsy complicating psittacosis. (1988) (9)
Tackling long-term morbidity and mortality after successful tuberculosis treatment. (2020) (9)
Children and adolescents in African countries should also be vaccinated for COVID-19 (2022) (9)
Crohn's disease and MAP (2004) (9)
Ethics of Healthcare Research in Developing Countries (2002) (9)
Killer respiratory tract infections: time to turn the tide. (2012) (9)
Treatment with human umbilical cord-derived mesenchymal stem cells for COVID-19 patients with lung damage: a randomised, double-blind, placebo controlled phase 2 trial (2020) (9)
Study of familial Parkinson’s disease in Russia, Uzbekistan, and Zambia (2005) (9)
Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection (2010) (9)
Role of pharmacogenetics in rifampicin pharmacokinetics and the potential effect on TB-rifampicin sensitivity among Ugandan patients. (2019) (9)
Genesis of EDCTP2. (2015) (9)
Host-directed therapies for tuberculous pericarditis. (2015) (9)
Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis (2022) (9)
Spatial modes for transmission of chikungunya virus during a large chikungunya outbreak in Italy: a modeling analysis (2020) (9)
Implementing a combined infection prevention and control with antimicrobial stewardship joint program to prevent caesarean section surgical site infections and antimicrobial resistance: a Tanzanian tertiary hospital experience (2020) (9)
World Tuberculosis Day 2021 Theme - 'THE CLOCK IS TICKING' - and the world is running out of time to deliver the United Nations General Assembly commitments to End TB due to the COVID-19 pandemic. (2021) (9)
Systems level immune response analysis and personalized medicine (2013) (9)
Operational research and MDG tuberculosis control targets. (2012) (9)
Is the Gulf War syndrome an immunologically mediated phenomenon? (1998) (9)
Taxonomy of medically important fungi in the molecular era (2013) (8)
Clinical Tuberculosis (2nd edition). J. Crofton, N. Horne & F. Miller. London and Basingstoke: MacMillan Education, 1999. xvi + 222pp. Price £3.50 plus £2.75 (p + p) (£3.75 airmail). ISBN 0-333-72430-5 (1999) (8)
TITLE: Post-Mortem Findings in Italian Patients with Covid-19 – a Descriptive Full Autopsy Study of cases with and without co-morbidities. (2021) (8)
Ciprofloxacin treatment of recurrent Salmonella typhimurium septicaemia in a splenectomized and immunosuppressed patient. (1988) (8)
Re-infection with a different SARS-CoV-2 clade and prolonged viral shedding in a hematopoietic stem cell transplantation patient (2021) (8)
Pulmonary Involvement during the Ebola Virus Disease (2019) (8)
Lethal zoonotic coronavirus infections of humans - comparative phylogenetics, epidemiology, transmission, and clinical features of coronavirus disease 2019, The Middle East respiratory syndrome and severe acute respiratory syndrome. (2021) (8)
COVID-19 and Sudden Unexpected Community Deaths in Lusaka, Zambia, Africa - A Medico-Legal Whole-Body Autopsy Case Series (2021) (8)
Advancing COVID-19 vaccines – avoiding different regulatory standards for different vaccines and need for open and transparent data sharing (2020) (8)
The Global Fund Round 11 cancellation fiasco: turning disaster into opportunity? (2012) (8)
Advances in the epidemiology, clinical features, diagnosis, clinical management and prevention of coronavirus disease 2019 (2022) (8)
Confronting the persisting threat of the Middle East respiratory syndrome to global health security (2019) (8)
Lujo viral hemorrhagic fever: considering diagnostic capacity and preparedness in the wake of recent Ebola and Zika virus outbreaks (2016) (8)
Outcomes of multidrug-resistant tuberculosis in Zambia: a cohort analysis (2017) (8)
Advancing political will to end the tuberculosis epidemic. (2017) (8)
Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection — Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base (2021) (8)
The challenges of cholera at the 2017 Hajj pilgrimage (2017) (8)
Tuberculosis in children, adolescents, and women. (2020) (8)
Advancing New diagnostic tests for Latent TB infection due multi-drug resistant strains of Mycobacterium tuberculosis - End of the road? (2020) (8)
Early or deferred initiation of efavirenz during rifampicin‐based TB therapy has no significant effect on CYP3A induction in TB‐HIV infected patients (2020) (8)
Predominance of one T-cell antigen receptor BV haplotype in African populations (2000) (8)
Tropical Diseases (2012) (8)
Peripheral T Cell Interferon-γ Responses and Latent Tuberculosis (2004) (7)
Children infected by human herpesvirus 6B with febrile seizures are more likely to develop febrile status epilepticus: A case‐control study in a referral hospital in Zambia (2018) (7)
A molecular and epidemiological study of Vibrio cholerae isolates from cholera outbreaks in southern Ghana (2020) (7)
Dried blood spot technology for CD4+ T-cell counting (2004) (7)
Engaging high and low burden countries in the "TB end game". (2016) (7)
Zika virus and microcephaly: is the correlation causal or coincidental? (2016) (7)
Transmission and prevention of acute viral respiratory tract infections in hospitals (2019) (7)
Tuberculosis series (2018) (7)
Mycobacterium tuberculosis proteins involved in cell wall lipid biosynthesis improve BCG vaccine efficacy in a murine TB model. (2017) (7)
Diagnosis of Chikungunya virus in febrile patients from a malaria holoendemic area. (2021) (7)
RESPIRE: The National Institute for Health Research's (NIHR) Global Respiratory Health Unit (2018) (7)
Referral times of Vietnamese refugees with tuberculosis in camps in Hong Kong. (2000) (7)
Neonatal sepsis and antibiotic resistance in developing countries. (2014) (7)
Global spread of antibiotic-resistant bacteria and mass-gathering religious events. (2018) (7)
Peripheral T cell interferon-gamma responses and latent tuberculosis. (2004) (6)
Enhancing preparedness for tackling new epidemic threats (2017) (6)
Early improvement of glycaemic control after virus clearance in patients with chronic hepatitis C and severe liver fibrosis: a cohort study. (2019) (6)
An Improved Fluorescent Amplified Fragment Length Polymorphism Method for Typing Mycobacterium tuberculosis (2006) (6)
IFN-γ Release Assays for Risk Assessment in Contacts of Patients with Tuberculosis in Low-Burden European Countries. (2015) (6)
Mobile-based and open-source case detection and infectious disease outbreak management systems: a review (2020) (6)
Predicting COVID-19 outcomes from clinical and laboratory parameters in an intensive care facility during the second wave of the pandemic in South Africa (2022) (6)
Adrenal function and the hypothalamo-pituitary adrenal axis in immunodeficiency virus-associated tuberculosis. (1997) (6)
Epidemiology, Pathogenesis, Clinical Features, Management, and Prevention (2019) (6)
Current trends and newer concepts on diagnosis, management and prevention of respiratory tract infections (2013) (6)
結核に対するXpert MTB/RIF検査 (2011) (6)
Specific COVID-19 messaging targeting ethnic minority communities (2021) (6)
HIV-1 seroprevalence in Zambian patients with acute diarrhea: a community-based study. (1999) (6)
Single-cell landscape of immunological responses in COVID-19 patients (2020) (6)
Randomised, placebo‐controlled trial to evaluate co‐trimoxazole to reduce mortality and morbidity in HIV‐infected post‐natal women in Zambia (TOPAZ) (2011) (6)
Comprar Mansons Tropical Diseases, 22nd edition Expert Consult | Alimuddin I. Zumla | 9781416044703 | Saunders (2009) (6)
Lung immunology in the Tropics. (1991) (6)
Problems of Developing Molecular Diagnostic Tests for Opportunistic Pathogens: The Example of Pneumocystis jirovecii (2006) (5)
Zika virus and microcephaly: is the correlation, causal or coincidental? (2016) (5)
Theorizing tuberculosis: a reply to Porter and Ogden (2002) (5)
Revolutionary new treatment regimens for multidrug-resistant tuberculosis. (2019) (5)
Commemorating World TB Day 2020: “IT’S TIME” — It’s time to End the Global TB Epidemic (2020) (5)
Research capacity strengthening in African countries (2010) (5)
World TB Day 2010 – New innovations are required for enhancing the global fight against Tuberculosis: the ‘Captain of all these men of death’ (2010) (5)
Strengthening tuberculosis control to advance towards elimination: The 2018 Rev. Port. Pneumol. (RPP) TB Series (2018) (5)
A serological study on primary hepatocellular carcinoma in Zambia. (1982) (5)
Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays. (2017) (5)
European Union conference on poverty-related diseases research. (2009) (5)
Host-directed therapies for COVID-19 (2021) (5)
Pattern of Respiratory Viruses among Pilgrims during 2019 Hajj Season Who Sought Healthcare Due to Severe Respiratory Symptoms (2021) (5)
Prognostic scoring system and risk stratification in patients with emphysematous pyelonephritis: an 11‐year prospective study at a tertiary referral centre (2020) (5)
Prognostic value of biochemical parameters among severe COVID-19 patients admitted to an intensive care unit of a tertiary hospital in South Africa (2022) (5)
Comparison of Established Diagnostic Methodologies and a Novel Bacterial smpB Real-Time PCR Assay for Specific Detection of Haemophilus influenzae Isolates Associated with Respiratory Tract Infections (2015) (5)
Be prepared: Europe needs Ebola outbreak consortium (2015) (5)
World Tuberculosis Day March 24th 2019 Theme: "It's TIME" - International Journal of Infectious Diseases Tuberculosis Theme Series. (2019) (5)
Triumphs, trials, and tribulations of the global response to MERS coronavirus (2014) (5)
Dengue outbreaks in Bangladesh: Historic epidemic patterns suggest earlier mosquito control intervention in the transmission season could reduce the monthly growth factor and extent of epidemics (2021) (5)
Emphysematous Pyelonephritis Prognostic Scoring System and Risk Stratification - an Eleven-Year Prospective Study at a Tertiary Referral Centre. (2020) (5)
Surgery and tuberculosis. (2012) (5)
The Host Battles Drug-Resistant Tuberculosis (2014) (5)
Congenital cytomegalovirus infections in sub‐Saharan Africa – a neglected and growing problem (2014) (5)
Extended Ecological Restoration of Bacterial Communities in the Godavari River During the COVID-19 Lockdown Period: a Spatiotemporal Meta-analysis (2021) (5)
Expression of TNF-Alpha-Dependent Apoptosis-Related Genes in the Peripheral Blood of Malagasy Subjects with Tuberculosis (2013) (5)
AIDS case definitions in developing countries (1993) (5)
The Global case-fatality rate of COVID-19 has been declining disproportionately between top vaccinated countries and the rest of the world (2022) (5)
Progress towards achieving global tuberculosis control: so near, yet so far. (2016) (5)
The ‘Global Emergency’ of Tuberculosis (1999) (5)
A global analysis of One Health Networks and the proliferation of One Health collaborations (2023) (5)
Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious Diseases (2021) (5)
SARS-CoV-2 cytopathogenesis in cultured cells and in COVID-19 autoptic lung, evidences of lipid involvement. (2020) (5)
Unique TCR β-subunit variable gene haplotypes in Africans (2002) (4)
Zoonotic disease preparedness in sub-Saharan African countries (2021) (4)
Middle East respiratory syndrome coronavirus – The need for global proactive surveillance, sequencing and modeling (2021) (4)
The where, when, and how of community-based versus clinic-based ART delivery in South Africa and Uganda (2020) (4)
Community-based interventions to reduce maternal mortality (2010) (4)
Comparison of patients with severe COVID-19 admitted to an intensive care unit in South Africa during the first and second wave of the COVID-19 pandemic (2021) (4)
Is the eradication of tuberculosis 'yesterday's ambition' or 'tomorrow's triumph'? (2010) (4)
Use of a murine T-cell hybridoma expressing human T-cell receptor α- and β-gene products as a tool for the production of human T-cell receptor-specific monoclonal antibodies (1992) (4)
DF-2 infection. May follow dog bites and hazardous to the immunosuppressed (1988) (4)
Non-randomised Ebola trials--lessons for optimal outbreak research. (2016) (4)
UN General Assembly tuberculosis targets: are we on track? (2020) (4)
Bedaquiline (BQ)-containing regimen at the programmatic level for MDR-TB: preliminary results (2017) (4)
Tuberculosis – the tide can be turned, the battle can be won (2008) (4)
Type 2 cytokines in respiratory syncytial virus bronchiolitis. (2004) (4)
Zoonotic tuberculosis-a call for an open One Health debate. (2020) (4)
Clinical and Imaging Features of Adults with Recurrent Pulmonary Tuberculosis - A Prospective Case-Controlled Study. (2021) (4)
Educational outreach to promote screening diagnosis and prevention of tuberculosis in primary care: a cluster randomised controlled trial (2007) (4)
World Tuberculosis Day 2022: aligning COVID-19 and tuberculosis innovations to save lives and to end tuberculosis (2022) (4)
Achieving sustainable development goals for HIV/AIDS in the Republic of the Congo - Progress, obstacles and challenges in HIV/AIDS health services. (2018) (4)
Is there sufficient evidence to repeal three decades of clinical research on chronic hepatitis C? (2018) (4)
Emerging Respiratory Infections in the 21st Century, An Issue of Infectious Disease Clinics (2010) (4)
Steroid metabolism and immunity: therapeutic implications. (1997) (4)
Spontaneous subcapsular splenic haematoma formation in infectious mononucleosis. (1989) (4)
Pneumocystis jirovecii in pleural infection: a nucleic acid amplification study (2010) (4)
Higher Death Rates in the Italian COVID-19 Outbreak: A Comparative Modelling Analysis of 8,342 Italy and 44,672 China Cases (2020) (4)
Advancing One human–animal–environment Health for global health security: what does the evidence say? (2023) (4)
Evaluation of SARS-CoV-2 diagnostics and risk factors associated with SARS-CoV-2 infection in Zambia (2022) (4)
MERS-CoV in Africa—an enigma with relevance to COVID-19 (2020) (4)
Prioritizing Pregnant Women for Coronavirus Disease 2019 Vaccination in African Countries (2022) (4)
One and a half years into the COVID-19 pandemic - exit strategies and efficacy of SARS-CoV-2 vaccines for holistic management and achieving global control (2021) (4)
Global and regional governance of One Health and implications for global health security (2023) (4)
How prepared is the world? Identifying weaknesses in existing assessment frameworks for global health security through a One Health approach (2023) (3)
Immunological and inflammatory profiles in mild and severe cases of COVID-19 (2020) (3)
MANAGEMENT AND MICROBIOLOGY OF BITES AND BURNS (1991) (3)
History of tuberculosis and drug resistance. (2013) (3)
Aligning New Tuberculosis Drug Regimens and Drug Susceptibility Testing: A Needs Assessment and Roadmap for Action (2014) (3)
Tuberculosis — An Epidemic of Injustice (1997) (3)
Towards optimal treatment for latent Mycobacterium tuberculosis infection. (2019) (3)
Nosocomial transmission of tuberculosis in HIV/AIDS units in London. (1997) (3)
Tuberculosis at post-mortem in inpatient adults at a tertiary referral centre in sub-Saharan Africa – A prospective descriptive autopsy study (2015) (3)
Mitigating the risks of global spread of Lassa fever at the 2018 Hajj pilgrimage. (2018) (3)
Epilogue: Politics, science and the 'new' tuberculosis (2003) (3)
Isolation of Campylobacter species from Zambian patients with acute diarrhoea. (1996) (3)
Host-directed therapy: tuberculosis vaccine development. (2015) (3)
Screening of immigrants in the UK for latent tuberculosis (2011) (3)
Looking for pathways related to COVID-19 phenotypes: Confirmation of pathogenic mechanisms by SARS-CoV-2 - Host interactome (2020) (3)
Effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of multidrug resistant tuberculosis (2016) (3)
Sarcoidosis and leprosy--an epidemiological, clinical, pathological and immunological comparison. (1989) (3)
Unique TCR beta-subunit variable gene haplotypes in Africans. (2002) (3)
New global estimates of malaria deaths (2012) (3)
Betrayal of trust (2002) (3)
Pediatric Tuberculosis and the HIV Epidemic (1997) (3)
Host directed therapies (HDTs) and immune response signatures: insights into a role for interleukin-32. (2015) (3)
Reducing the threat of epidemic-prone infections at mass gathering religious events (2022) (3)
Clinical trial research in focus: overcoming barriers in MDR-TB clinical trials. (2017) (3)
Antimicrobial Resistance Patterns and Risk Factors Associated with Salmonella spp. Isolates from Poultry Farms in the East Coast of Peninsular Malaysia: A Cross-Sectional Study (2021) (3)
To have sepsis or to be septic-is the difference between these clinical conditions important? (2016) (3)
Mandatory immunization against SARS-CoV-2 of athletes, companions and supporters for the Tokyo Olympics (2021) (3)
Urgent need for multi-site controlled trials for CMV pneumonia treatment in African children. (2018) (3)
Cardiac Cysticercosis and Neuro Cysticercosis in Sudden and Unexpected Community Deaths in Lusaka, Zambia - A Descriptive Medico-Legal Post-Mortem Examination Study. (2021) (3)
Genetic diversity of hepatitis E virus (HEV) in imported and domestic camels in Saudi Arabia (2022) (3)
Current opinion in pulmonary medicine: Introduction (2008) (3)
Emerging respiratory infections in the 21st century. Preface. (2010) (2)
The war in Ukraine and potential consequences for the TB epidemic in Europe. (2022) (2)
Tropical Diseases: definition, Geographic Distribution, Transmission and Classification (2013) (2)
WITHDRAWN: ‘COVID-19 and the scaled-down 2020 Hajj Pilgrimage - Decisive, logical and prudent decision making by Saudi authorities overcomes pre-Hajj public health concerns’ (2020) (2)
Common childhood illnesses and HIV infection in Africa. (1994) (2)
Haematological predictors of poor outcome among COVID-19 patients admitted to an intensive care unit of a tertiary hospital in South Africa (2022) (2)
Middle East Respiratory Syndrome Coronavirus (2021) (2)
The role of nucleic acid amplification techniques (NAATs) in the diagnosis of infective endocarditis (2010) (2)
AETIOLOGY, ANTIBIOTIC RESISTANCE AND RISK FACTORS FOR NEONATAL SEPSIS IN A LARGE REFERRAL CENTRE IN ZAMBIA (2017) (2)
Relevance of genomic diversity of Mycobacterium tuberculosis complex in Africa. (2022) (2)
Editorial: emerging respiratory infections in the 21st century. (2009) (2)
Respiratory tract infections in community and healthcare settings: epidemiological, diagnostic and management challenges. (2015) (2)
Editorial: Coronavirus disease 2019 (COVID-19) – advances in epidemiology, diagnostics, treatments, host-directed therapies, pathogenesis, vaccines, and ongoing challenges (2021) (2)
Rescue of Replication-Competent ZIKV Hidden in Placenta-Derived Mesenchymal Cells Long After the Resolution of the Infection (2019) (2)
The Qatar FIFA World Cup 2022 and camel pageant championships increase risk of MERS-CoV transmission and global spread. (2022) (2)
SARS-CoV-2-specific immunoglobulin Y antibodies are protective in infected mice (2022) (2)
BACTEREMIAS IN HIV-POSITIVE PATIENTS (1990) (2)
Xpert® MTB/RIF assay testing on stool for the diagnosis of paediatric pulmonary TB in Tanzania. (2021) (2)
Incremental Value Of Interferon-Gamma Release Assays For Diagnosis Of Active Tuberculosis In Smear-Negative Patients In A High-Burden Setting: A Multivariable Analysis (2010) (2)
Anti-tuberculosis agents (2003) (2)
IL-7δ5 protein is expressed in human tissues and induces expression of the oxidized low density lipoprotein receptor 1 (OLR1) in CD14+ monocytes. (2017) (2)
LEGIONNAIRES' DISEASE: EARLY LESSONS FROM 1988 LONDON OUTBREAK (1988) (2)
Infectious Diseases Clinics of North America -Tropical Diseases volume (2012) (2)
Limiting consumption in tuberculosis: current concepts in anti-tuberculosis treatment in the critically ill patient (2018) (2)
Infection control at mass religious gatherings (2022) (2)
Commemorating World Tuberculosis Day 2015. (2015) (2)
Autoantibodies and tropical infections. (1990) (2)
Sarcoidosis and leprosy: a comparative perspective (1994) (2)
Protection from Pneumocystis carinii pneumonia. (1999) (2)
Long-term effect of SARS-CoV-2 infection on cardiovascular outcomes and all-cause mortality (2022) (2)
Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Pregnancy in Sub-Saharan Africa: A 6-Country Retrospective Cohort Analysis (2022) (2)
World TB Day 2010: eradicating tuberculosis in sub-Saharan Africa needs effective and committed north-south partnerships. (2010) (2)
Making DOTS succeed. Directly Observed Treatment, Short Course. (1997) (2)
Tuberculosis and HIV - perspectives from sub-Saharan Africa. (1999) (2)
Mimics of sarcoidosis. Leprosy. (1991) (2)
Expression of a common idiotype PR4 in the sera of patients with leprosy. (1991) (2)
The health of prisoners (2011) (2)
B cells or T cells in TB: a continuing conundrum. (2018) (2)
Optimising tuberculosis care for refugees affected by armed conflicts. (2022) (2)
BCG vaccination in children (2008) (1)
Preliminary findings from the London TB link project targeting homeless and marginalised groups (2004) (1)
Isoniazid preventive therapy for children in sub-Saharan Africa. (2019) (1)
Use of a murine T-cell hybridoma expressing human T-cell receptor alpha- and beta-gene products as a tool for the production of human T-cell receptor-specific monoclonal antibodies. (1992) (1)
Emerging respiratory tract infections 4 Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections—needs, advances, and future prospects (2014) (1)
The cutaneous manifestations of mycobacterial diseases (1998) (1)
Xpert MTB/RIF test for tuberculosis (2011) (1)
THE SPECTRUM OF GASTRITIS IN ZAMBIAN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME (1995) (1)
Preface: tropical diseases. (2012) (1)
Chapter 15 – Human tuberculosis due to Mycobacterium bovis and related animal pathogens (2009) (1)
A postgraduate qualification in TB, message in a bottle. (2020) (1)
Treating drug-resistant tuberculosis (2012) (1)
Blue Skies research is essential for ending the Tuberculosis pandemic and advancing a personalized medicine approach for holistic management of Respiratory Tract infections. (2022) (1)
Thoracic empyema: a 12 year experience from a UK tertiary cardiothoracic Centre (2012) (1)
New tools for achieving tuberculosis control: progress and reflexion. (2011) (1)
Hydatid disease. (1970) (1)
Tuberculosis, Public Health Aspects (2017) (1)
Corticosteroid therapy for pneumonia (2015) (1)
Multi-Drug/Extensively Drug Resistant Tuberculosis -Epidemiology, Clinical Features, Management and Treatment (2020) (1)
Seek TB, a Two-Stage Multiplex Real-Time-PCR-Based Method for Differentiation of the Mycobacterium tuberculosis Complex (2012) (1)
Infectious diseases threats at the Arba'een - a neglected but one of the largest annually recurring mass gathering religious events. (2022) (1)
Reflexión y reacción: medicamentos para enfermedades olvidadas (2004) (1)
Surgery and Salmonella. (1990) (1)
Pregnancy and infection. (2014) (1)
COVID-19 Disease - Temporal Analyses of Complete Blood Count Parameters Over Course of Illness, and Relationship to Patient Demographics and Management Outcomes in Survivors and Non-Survivors: A Longitudinal Descriptive Cohort Study (2020) (1)
Tropical Diseases Preface (2012) (1)
High Genetic Diversity of Human Rhinovirus among Pilgrims with Acute Respiratory Tract Infections during 2019 Hajj Pilgrimage Season. (2022) (1)
Handbook of Refugee Health (2021) (1)
Rapid Imunodiagnosis of Site-Specific Tuberculosis: Is It Useful in Clinical Practice in South Africa? (2009) (1)
Rift Valley fever seropositivity in humans and domestic ruminants and associated risk factors in Sengerema, Ilala and Rufiji districts, Tanzania. (2022) (1)
Tobacco Smoking And Spectrum Of Tuberculosis Infection And Disease In South African Patients With Suspected Tuberculosis (2010) (1)
The Evolution of Clinical and Scientific Evidence-Based Management Guidelines for COVID-19 Disease: A Longitudinal Descriptive Analysis (2020) (1)
Tuberculosis and Co-infection with the Human Immunodeficiency Virus (2004) (1)
Incidental Tuberculosis in sudden, unexpected, or violent deaths in the community Lusaka, Zambia - A descriptive forensic post-mortem examination study. (2022) (1)
Basic Reproduction Number of Chikungunya Virus Transmitted by Aedes Mosquitoes (2020) (1)
Too hard on tropical medicine? (2004) (1)
Understanding community-acquired respiratory tract infections: new concepts of disease pathogenesis and new management strategies. (2016) (1)
Mansons Tropical Diseases, 22nd edition Expert Consult (2009) (1)
A comparison of vitamin D and cathelicidin (LL-37) levels between patients with active TB and their healthy contacts in a high HIV prevalence setting: a prospective descriptive study (2021) (1)
M. tuberculosis induces selective upregulation of Toll-like receptors in the mononuclear leukocytes of patients with active pulmonary tuberculosis (2006) (1)
Cover Editorial- IJID World TB Day 2020 Theme Series. (2020) (1)
Middle East respiratory syndrome [Review] (2020) (1)
IgY antibodies: The promising potential to overcome antibiotic resistance (2023) (1)
A 10-year Review of TB Notifications and Mortality Trends Using a Joint Point Analysis in Zambia - a High TB burden country: Invited article - IJID World TB Day Series 2022. (2022) (1)
The relentless and persistent global threat of a range of pulmonary infections. (2010) (1)
Superantigens--progress in understanding microbial pathogenesis. (1992) (1)
The monkeypox outbreak must amplify hidden voices in the global discourse (2022) (1)
Infectious Diseases —A Treatise of Infectious Processes, Hoeprich PD, Jordan MC, Ronald AR. J. B. Lipincott Company, Philadelphia (1996), 1532 pages, Price: £176, ISBN: 0-397-51296-1 (1997) (1)
Smoking is not beneficial for tuberculosis. Author's reply (2004) (1)
The re-emergence of Marburg virus Disease in West Africa: how prepared is the sub-region for preventing recurrent zoonotic outbreaks? (2023) (1)
Tuberculosis. Preface. (2009) (1)
DYSGONIC FERMENTER TYPE 2 INFECTION (1989) (1)
High-income countries and latent tuberculosis infection screening for migrants - Authors' reply. (2019) (1)
Advances in development of new tuberculosis vaccines (2023) (1)
Malaria prophylaxis--a persisting dilemma. (1989) (1)
Multi-drug Resistant Tuberculosis Management (2021) (1)
European bodies can help to tackle TB worldwide. (2009) (1)
Lessons for tuberculosis from scrutiny of HIV/AIDS and Malaria UK Parliamentary Questions. (2015) (1)
TB-HAART trial--authors' reply. (2015) (1)
Globalisation of antibiotic-resistant bacteria at recurring mass gathering events (2022) (1)
New developments in the epidemiology, diagnosis, treatment and prevention of respiratory tract infections. (2014) (1)
Chapter 73 – Priorities in tuberculosis research (2009) (1)
A decade of interferon-γ release assays: quest for the holy grail to diagnose latent infection with mycobacterium tuberculosis? (2011) (1)
EMERGENCE OF LEISHMANIASIS IN THE WAKE OF AIDS (1989) (1)
Immunological Aspects of Tropical Diseases (2003) (1)
Editorial: Toward improving the diagnosis, treatment and prevention of community acquired and nosocomial respiratory tract infections. (2019) (1)
The cursed duet today: TB and HIV-coinfection (2018) (1)
Towards improving outcomes of fatal pulmonary infections. (2005) (1)
Errata : new drugs for the treatment of tuberculosis : needs, challenges, promise, and prospects for the future (Journal of Infectious Deseases, vol. 205, p. S241-S249, 2012) (2012) (1)
148 – Antituberculosis Agents (2017) (1)
Antimicrobial resistance preparedness in sub-Saharan African countries (2020) (0)
O03 The impact of COVID-19 infection prevention and control measures on transmission of hospital-acquired infections and antimicrobial resistance in Africa (2022) (0)
Title : Prevalence and risk factors for betaherpesvirus DNAemia in infants aged between 3 weeks and 2 years of age , admitted to a large referral hospital in sub-Saharan Africa (2017) (0)
Lymph nodes and pathogenesis of infection with HIV-1 (2010) (0)
Update in Mycobacterium tuberculosis lung disease 2014. (2015) (0)
Advancing detection and response capacities for emerging and re-emerging pathogens in Africa (2022) (0)
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown (2023) (0)
Genetic diversity of hepatitis E virus (HEV) in imported and domestic camels in Saudi Arabia (2022) (0)
Treating AIDS: a new approach (2003) (0)
Latent class analysis: an innovative approach for identification of clinical and laboratory markers of disease severity among COVID-19 patients admitted to the intensive care unit (2022) (0)
Editorial: Coronavirus disease 2019 (COVID-19) - advances in epidemiology, diagnostics, treatments, host-directed therapies, pathogenesis, vaccines, and ongoing challenges (2022) (0)
Middle East respiratory syndrome coronavirus—a 10-year (2012-2022) global analysis of human and camel infections, genomic sequences, lineages, and geographical origins (2023) (0)
H u m a n M o n k e y p o x Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention (2019) (0)
Toward a New Paradigm of North–South and South–South Partnerships for Pandemic Preparedness: Lessons Learned from COVID-19 and Other Outbreaks (2022) (0)
Zero by 2030 and OneHealth: The multidisciplinary challenges of rabies control and elimination. (2022) (0)
A pandemic within a pandemic? Admission to COVID-19 wards in hospitals is associated with increased prevalence of antimicrobial resistance in two African settings (2023) (0)
Tuberculosis and HIV infection (1994) (0)
Immunometabolism: new insights and lessons from antigen-directed cellular immune responses (2020) (0)
Contents (2019) (0)
Infectious diseases. (2006) (0)
2 d the IL-4 Antagonist IL-4 Express High Levels of Th1 Cytokines and Mycobacterium tuberculosis Infection with Healthy Individuals That Control a Latent (2004) (0)
Editorial overview: Infectious diseases. (2002) (0)
Mycobacterium vaccae to control the Th2 immune system activity (1999) (0)
Lung Immunology and HIV (1997) (0)
The challenges, value and impact of conducting qPCR in the developing world (2009) (0)
Textbook-atlas of intestinal infections in AIDS: Daniele Dionisio (editor). Milan: Springer-Verlag Italia, 2003. xvi + 506 pp. Price $129.00. ISBN 88-470-0174-9 (2003) (0)
C URRENT OPINION Current trends and newer concepts on diagnosis, management and prevention of respiratory tract infections (2013) (0)
Lung remodelling in tuberculosis (2005) (0)
Appendix B – Approach to a 12-Lead ECG (2005) (0)
Chapter 143 – Antituberculosis agents (2010) (0)
Clinical characteristics and outcomes of confirmed COVID-19 patients in the early months of the pandemic in Tanzania: a multicenter cohort study (2022) (0)
Children infected by HHV-6B with febrile seizures are more likely to develop febrile status epilepticus: a case control study in a referral hospital in Zambia (2018) (0)
Tuberculosis - comprehensive clinical reference International Edition isbn 97881416039884 (2009) (0)
Sinusitis and sinus disease in HIV infection (1997) (0)
Mycobacterium vaccae for use of the treatment of chronic fatigue. (1997) (0)
Health and philanthropy—the tobacco connection (2011) (0)
Investigating molecular diagnosis of tuberculosis using transrenal DNA. The nucleic acid extraction step. (2005) (0)
Characterization of Pediatric AIDS/HIV-1 Infection in Zambia (1993) (0)
Parasites and HIV-related diarrhoea. (1995) (0)
Lung Immunology in the Tropics. Chapter 1 (1991) (0)
Human Disease due to Environmental Mycobacteria (2003) (0)
Fever in the returning traveler (2021) (0)
Influence of severity of illness on the effects of eritoran tetrasodium ( E 5564 ) , a TLR 4 antagonist , in patients with severe sepsis (2015) (0)
Treatment of drug-resistant tuberculosis reply (2011) (0)
Global mass gathering events and deaths due to crowd surge, stampedes, crush and physical injuries - Lessons from the Seoul Halloween and other disasters. (2022) (0)
Current Opinion in Pulmonary Medicine: Editorial introduction (2009) (0)
Consequences and Global Risks of Highly Pathogenic Avian Influenza outbreaks in poultry in the United Kingdom. (2023) (0)
Peripheral T cell interferon-γ responses and latent tuberculosis [5] (multiple letters) (2004) (0)
Appendix 4 – Tuberculosis research funding (2009) (0)
Genomic Surveillance of SARS-CoV-2 in the Southern Province of Zambia: Detection and Characterization of Alpha, Beta, Delta, and Omicron Variants of Concern (2022) (0)
Contents (2010) (0)
Infection in Hospitals (1998) (0)
326 SARS-CoV-2 specific T-cells in TIL from patients with epithelial cancer (2020) (0)
Editorial (2019) (0)
Increased IL-6 Levels Correlate with Severity of Lung Damage and Early Death in Tanzanian Patients with Pulmonary Tuberculosis (2018) (0)
TB in children, adolescents and women – continuing challenges AUTHORS: (2020) (0)
BCG vaccination in children : Can be given percutaneously rather than intradermally, if necessary (2008) (0)
Pulmonary infections: 'le terrain est tout, le microbe n'est rien'. (2011) (0)
Tuberculosis and HIV infection [letter] (1994) (0)
Delamanid expanded access novel treatment of drug resistant tuberculosis [Corrigendum] (2016) (0)
Are there subtle abnormalities of glucocorticoid metabolism in active pulmonary tuberculosis which affect immune responses (1997) (0)
Topical zoonosis. (1989) (0)
Chloroquine and proguanil prophylaxis in travellers to Kenya. (1992) (0)
Expression of IL-4 mRNA in peripheral blood mononuclear cells from normal donors in relation to expression of TLR2. (2006) (0)
David Geraint James Obituary (2010) (0)
Emerging and Re-Emerging Infectious Diseases (2019) (0)
Preventing pellagra during isoniazid preventive treatment. (2022) (0)
Emerging respiratory tract infections 1 Surveillance for emerging respiratory viruses (2014) (0)
Development of a real time PCR assay for detection of Pneumocystitis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients (2007) (0)
Field's Virology, Fields BN, Knipe DM, Howley PM. Lipincott-Raven, Carnforth (1996), 3216 pages, Price: £226.50, ISBN: 0-7817-0253-4 (1997) (0)
Optimizing the benefits of pneumococcal vaccination in the Kingdom of Saudi Arabia (2016) (0)
Comprar Emerging Respiratory Infections In The 21st Century, An Issue Of Infectious Disease Clinics, Vol. 24-3 | Alimuddin I. Zumla | 9781437724608 | Saunders (2010) (0)
Price: £226.50BN Fields, DM Knipe and PM Howley, Field's Virology, Lipincott-Raven, Carnforth (1996) ISBN 0-7817-0253-4, p. 3216 pages. (1997) (0)
Preface - Tropical lung disease (2002) (0)
Malaria in spite of chemoprophylaxis. (1989) (0)
Erratum: Department of error (The Lancet (2014) 383 (1869-1872) (2014) (0)
Future diagnosis of sepsis – Authors' reply (2010) (0)
Tuberculosis - operational aspects (1999) (0)
C URRENT OPINION Emerging respiratory tract viral infections (2015) (0)
Appendix A – Normal Ranges (2005) (0)
Prognostic Value of Baseline Biochemical Parameters Among Severe COVID-19 Patients Admitted to an Intensive Care Unit of a Tertiary Hospital in South Africa. (2021) (0)
Price: £176PD Hoeprich, MC Jordan and AR Ronald, Infectious Diseases —A Treatise of Infectious Processes, J. B. Lipincott Company, Philadelphia (1996) ISBN 0-397-51296-1, p. 1532 pages. (1997) (0)
Comprar Tuberculosis, An Issue of Clinics in Chest Medicine | Alimuddin I. Zumla | 9781437718041 | Saunders (2010) (0)
Glucocorticoids and Acute Pulmonary Tuberculosis: a clue to pathogenesis? (1997) (0)
Variations in climate and global spread of COVID-19: Implications for control in tropical and warmer climates (2020) (0)
The economics and financing of tropical and infectious diseaseprogrammes. (2009) (0)
Lung immunology in AIDS patients (1997) (0)
Galloping consumption. (1998) (0)
PO 8518 LATENT TUBERCULOSIS INFECTION DETECTION BY IGRA USING MYCOBACTERIUM TUBERCULOSIS ALTERNATIVE DESATURASE A1 IMMUNE-DOMINANT ANTIGEN (2019) (0)
Chapter 2 Human Cytomegalovirus ( HCMV ) Infection in Sub-Saharan Africa (2013) (0)
Reduced Levels of Gamma Interferon Elevated Levels of Interleukin-4 and Contacts of Tuberculosis Patients Express Target-Responsive , Asymptomatic The 6-Kilodalton Early Secreted Antigenic (2006) (0)
P67 Outcomes from surgical management of pleural infection: 12-year experience from a tertiary cardiothoracic centre (2010) (0)
Tuberculosis : a subject collection from Cold Spring Harbor perspectives in medicine (2015) (0)
edicine 10:157-158. 11. Huggett J, Dheda K, Zumla A, Rook G. (2004) (0)
Accelerating the development of therapeutic strategies for drug-resistant tuberculosis (2018) (0)
Extensively drug-resistant tuberculosis in South Africa – Authors' reply (2010) (0)
[Epidemiology of tuberculosis]. (2004) (0)
World Tuberculosis Day 2023 theme “Yes! We Can End TB!” (2023) (0)
Purpura and sepis–rarer causes? (1989) (0)
Book of the Month: Betrayal of Trust (2002) (0)
P593 – TCRβV allelic frequencies in africans and caucasians (1996) (0)
Patients with acute pulmonary tuberculosis (Tb) have subtle abnormalities of glucocorticoid metabolism which may affect immune responses (1997) (0)
C URRENT OPINION Surgery and tuberculosis (2012) (0)
Extensively drug-resistant tuberculosis in South Africa Reply (2010) (0)
University of Groningen Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis Kroesen (2017) (0)
Current opinions on selected respiratory infections causing global morbidity and mortality. (2008) (0)
100 Short Cases for the MRCP (2020) (0)
Hepatitis E Virus (HEV) in Imported and Domestic Camels in Saudi Arabia – A Cross-Sectional Descriptive Molecular Study (2021) (0)
Comprar Tropical Diseases, An Issue of Infectious Disease Clinics | Jennifer Keiser | 9781455738809 | Saunders (2012) (0)
Human Zika infection induces a reduction of IFN-γ producing CD4 T-cells and a parallel expansion of effector Vδ2 T-cells (2017) (0)
Torasik ampiyem: tıbbi ve cerrahi tedavide güncel görüşler (2010) (0)
Travel medicine. (2012) (0)
Historical perspective: other human coronavirus infectious diseases, SARS and MERS (2021) (0)
Fibrosing Alveolitis (2020) (0)
Preface (2010) (0)
IL-4 Delta 2 and Th2 cytokines in human pulmonary tuberculosis (2004) (0)
Sinusitis and sinus disease (1997) (0)
AID® ELISPOT reader images of T-SPOT®. TB wells demonstrating. (2013) (0)
A Guide to the MRCP Part 2 Written Paper 2Ed (2005) (0)
Comprar Tuberculosis - A Comprehensive Clinical Reference | Alimuddin I. Zumla | 9781416039884 | Saunders (2008) (0)
Tropical Lung Diseases CLINICS IN CHEST MEDICINE (2002) (0)
Infectious diseases - editorial overview (2001) (0)
Paediatric TB and the Human Immunodeficiency Virus Epidemic (1997) (0)
Editorial introductions. (2020) (0)
Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of multidrug-resistant tuberculosis (2016) (0)
Spread of neisseria meningitidis group A, Clone III-I meningitis into Zambia. A two year prospective study (1997) (0)
Tuberculosis: an international interdisciplinary agenda: (2003) (0)
The changing incidence of mycobacterial infections in an HIV plus VE population. (2000) (0)
HEALTH MIRACLES IN THE HOLY-KORAN (1990) (0)
AIDS case definitions in developing countries [letter] (1993) (0)
Hepatitis E Virus (HEV) in Makkah, Saudi Arabia: A Population-Based Seroprevalence Study (2023) (0)
Steroid Metabolism and Immunity (1997) (0)
Book Review (1996) (0)
Abstracts of the Eighth EDCTP Forum, 6–9 November 2016 (2017) (0)
Purpura and sepsis--rarer causes? (1989) (0)
Dried blood spot technology for CD4+T-cell counting - Reply (2004) (0)
Patients with acute pulmonary tuberculosis (Tb) have subtle but crucial abnormalities of steroid metabolism which may persist after cure or be constitutive (1997) (0)
Infectious Diseases (2017) (0)
TCR beta V allelic frequencies in Africans and Caucasians (1996) (0)
The association between acid–base status and clinical outcome in critically ill COVID-19 patients admitted to intensive care unit with an emphasis on high anion gap metabolic acidosis (2022) (0)
Treatment of drug-resistant tuberculosis – Authors' reply (2011) (0)
MCQs for the MRCP (1993) (0)
COLONIC ENTEROADHERENT BACTERIA (EAB) IN AIDS PATIENTS WITH CHRONIC DIARRHEA AND WASTING IN ZAMBIA - CORRELATION OF CLINICAL, ENDOSCOPIC AND PATHOLOGICAL FINDINGS (1994) (0)
Title : Different screening strategies ( single or dual ) for the diagnosis of suspected latent tuberculosis : a cost-effectiveness analysis (2009) (0)
David Geraint James (2010) (0)
Performance evaluation and further development of the PCR and microarray-based Prove-it™ Sepsis assay (2009) (0)
Tuberculosis (1998) (0)
Antibiotici ad uso specifico (2016) (0)
Editorial introductions. (2016) (0)
Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19) (2020) (0)
Implementing a combined infection prevention and control with antimicrobial stewardship joint program to prevent caesarean section surgical site infections and antimicrobial resistance: a Tanzanian tertiary hospital experience (2020) (0)
A qualitiative investigation into the experience of postnatal depression in Asian women. (2008) (0)
Detection and characterization of carbapenem resistant Gram‐negative bacilli isolates recovered from hospitalized patients at Soba University Hospital, Sudan (2021) (0)
Emerging respiratory tract infections 5 Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options (2014) (0)
Novel intervention to promote COVID-19 protective behaviours among Black and South Asian communities in the UK: protocol for a mixed-methods pilot evaluation (2023) (0)
The disproportionate case–fatality ratio of COVID-19 between countries with the highest vaccination rates and the rest of the world (2023) (0)
Luna Virus and Helminths in Wild Mastomys natalensis in Two Contrasting Habitats in Zambia: Risk Factors and Evidence of Virus Dissemination in Semen (2022) (0)
Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy in COVID-19 Patients: A Phase 1 Clinical Trial (2020) (0)
‘Disease X’—time to act now and prepare for the next pandemic threat (2022) (0)
World tuberculosis day 2023 - Reflections on the spread of drug-resistant tuberculosis by travellers and reducing risk in forcibly displaced populations. (2023) (0)
General Approach to the Patient (2003) (0)
measure CD4+ lymphocyte counts in HIV-1-infected patients (2003) (0)
Global mass gathering events and deaths due to crowd surge, stampedes, crush and physical injuries - Lessons from the Seoul Halloween and other disasters. (2022) (0)
Editorial introductions. (2019) (0)
End of the Bedaquiline patent - a crucial development for moving forward affordable drugs, diagnostics, and vaccines for infectious diseases in low- and middle-income countries. (2023) (0)
Organism Fungi Aspergillus flavus Aspergillus fumigatus Aspergillus niger Aspergillus terreus Candida glabrata Candida kruseii Candida parapsilosis Candida tropicalis Cryptococcus sp . Pneumocystis carinii & Pneumocystis wakefieldiae Pneumocystis jirovecii Pneumocystis murina Saccharomyces cerevisia (2007) (0)
Epidemiology of viral hepatitis in men who have sex with men in Mediterranean Europe: a region-wide sero-surveillance in Rome (Italy) (2020) (0)
Lujoウイルス性出血熱:最近のエボラおよびジカウイルス発生の伴流における診断能力と準備を考慮した【Powered by NICT】 (2016) (0)

This paper list is powered by the following services:

Other Resources About Alimuddin Zumla

What Schools Are Affiliated With Alimuddin Zumla?

Alimuddin Zumla is affiliated with the following schools:

Alimuddin Zumla's Academic­Influence.com Rankings

Alimuddin Zumla's Degrees

Why Is Alimuddin Zumla Influential?

Alimuddin Zumla's Published Works

Published Works

Other Resources About Alimuddin Zumla

What Schools Are Affiliated With Alimuddin Zumla?

Image Attributions

Alimuddin Zumla's AcademicInfluence.com Rankings